156 related articles for article (PubMed ID: 9037212)
1. Commentary on: 'Effect of purified soluble urokinase receptor on the plasminogen prourokinase activation system' by N. Behrendt and K. Dano, FEBS Letters, 393 (1996) 31-36.
Higazi AA
FEBS Lett; 1997 Feb; 402(2-3):291-2. PubMed ID: 9037212
[No Abstract] [Full Text] [Related]
2. Reply to comment on 'Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system' (A. A-R. Higazi).
Behrendt N; Danø K
FEBS Lett; 1997 Feb; 402(2-3):293-4. PubMed ID: 9037213
[No Abstract] [Full Text] [Related]
3. Effect of purified, soluble urokinase receptor on the plasminogen-prourokinase activation system.
Behrendt N; Danø K
FEBS Lett; 1996 Sep; 393(1):31-6. PubMed ID: 8804418
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activation by receptor-bound urokinase.
Ellis V; Danø K
Semin Thromb Hemost; 1991 Jul; 17(3):194-200. PubMed ID: 1665584
[No Abstract] [Full Text] [Related]
5. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
Ellis V; Whawell SA; Werner F; Deadman JJ
Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of reciprocal pro-urokinase/plasminogen activation--stimulation by a template formed by the urokinase receptor bound to poly(D-lysine).
Petersen LC
Eur J Biochem; 1997 Apr; 245(2):316-23. PubMed ID: 9151959
[TBL] [Abstract][Full Text] [Related]
7. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
8. Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors.
Blasi F; Vassalli JD; Danø K
J Cell Biol; 1987 Apr; 104(4):801-4. PubMed ID: 3031083
[No Abstract] [Full Text] [Related]
9. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hasui Y; Osada Y
J Natl Cancer Inst; 1997 Nov; 89(21):1630-1. PubMed ID: 9362166
[No Abstract] [Full Text] [Related]
10. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
11. Binding of single-chain prourokinase to the urokinase receptor of human U937 cells.
Cubellis MV; Nolli ML; Cassani G; Blasi F
J Biol Chem; 1986 Dec; 261(34):15819-22. PubMed ID: 3023326
[TBL] [Abstract][Full Text] [Related]
12. Specific inhibition of the activity of the urokinase receptor-mediated cell-surface plasminogen activation system by suramin.
Ellis V; Danø K
Biochem J; 1993 Dec; 296 ( Pt 2)(Pt 2):505-10. PubMed ID: 8257443
[TBL] [Abstract][Full Text] [Related]
13. The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.
Behrendt N; List K; Andreasen PA; Danø K
Biochem J; 2003 Apr; 371(Pt 2):277-87. PubMed ID: 12534347
[TBL] [Abstract][Full Text] [Related]
14. The growth factor module of urokinase is the binding sequence for its receptor.
Appella E; Blasi F
Ann N Y Acad Sci; 1987; 511():192-5. PubMed ID: 2830824
[No Abstract] [Full Text] [Related]
15. Re: urokinase and urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Duffy MJ; Duggan C
J Natl Cancer Inst; 1997 Nov; 89(21):1628-30. PubMed ID: 9362165
[No Abstract] [Full Text] [Related]
16. Regulated localization confers multiple functions on the protease urokinase plasminogen activator.
Wells JM; Strickland S
J Cell Physiol; 1997 May; 171(2):217-25. PubMed ID: 9130470
[TBL] [Abstract][Full Text] [Related]
17. Activation of plasminogen by pro-urokinase. II. Kinetics.
Collen D; Zamarron C; Lijnen HR; Hoylaerts M
J Biol Chem; 1986 Jan; 261(3):1259-66. PubMed ID: 2935529
[TBL] [Abstract][Full Text] [Related]
18. Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells.
Dumler I; Petri T; Schleuning WD
FEBS Lett; 1994 Apr; 343(2):103-6. PubMed ID: 8168613
[TBL] [Abstract][Full Text] [Related]
19. Interaction of urokinase A chain with the receptor of human keratinocytes stimulates release of urokinase-like plasminogen activator.
Fibbi G; Magnelli L; Pucci M; Del Rosso M
Exp Cell Res; 1990 Mar; 187(1):33-8. PubMed ID: 2153567
[TBL] [Abstract][Full Text] [Related]
20. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.
Colman RW; Pixley RA; Najamunnisa S; Yan W; Wang J; Mazar A; McCrae KR
J Clin Invest; 1997 Sep; 100(6):1481-7. PubMed ID: 9294114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
